RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells
about
The PTEN tumor suppressor gene and its role in lymphoma pathogenesisPTEN modulators: a patent reviewMAPK ERK signaling regulates the TGF-beta1-dependent mosquito response to Plasmodium falciparumSingle cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell linesPTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in miceTGF-β induces phosphorylation of phosphatase and tensin homolog: implications for fibrosis of the trabecular meshwork tissue in glaucomaSignaling via Alk5 controls the ontogeny of lung Clara cells.Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.PTEN loss accelerates KrasG12D-induced pancreatic cancer developmentCaveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition.A specific role for phosphoinositide 3-kinase and AKT in osteoblasts?Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans.Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabineDp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic miceTGF-beta downregulates PTEN via activation of NF-kappaB in pancreatic cancer cells.Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma.Signaling cross-talk between TGF-beta/BMP and other pathways.Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting p65 to Upregulate PTEN Expression.Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis.The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy.Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.SMAD4 and its role in pancreatic cancer.TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells.TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell functionPTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma.Inflammation-related signaling pathways implicating TGFβ are revealed in the expression profiling of MCF7 cell treated with fermented soybean, chungkookjang.Molecular mechanisms underlying Ca2+-mediated motility of human pancreatic duct cells.TGFbeta modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells.TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells.Imbalanced expression of Tif1γ inhibits pancreatic ductal epithelial cell growth.Mechanisms of TGFbeta inhibition of LUNG endodermal morphogenesis: the role of TbetaRII, Smads, Nkx2.1 and Pten.MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.Genetic status of KRAS modulates the role of Neuropilin-1 in tumorigenesis.The role of ERK1/2 in 15-HETE-inhibited apoptosis in pulmonary arterial smooth muscle cells.Molecular mediators involved in Ferulago campestris essential oil effects on osteoblast metabolism.Role of ERK/mTOR signaling in TGFbeta-modulated focal adhesion kinase mRNA stability and protein synthesis in cultured rat IEC-6 intestinal epithelial cells.Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
P2860
Q26776527-5D9F738D-AA6A-49BD-B176-7CFD6BEFC983Q26995513-E16ECCDA-2022-44CB-ADFA-CE3628925171Q28475123-759BF617-1D3D-4867-975C-1ADDF6B886F0Q28483475-99881F89-9C81-4963-9706-1939650BC4E3Q33608760-5D52F1FF-0FB6-4DDA-8616-9D58D6BC61FAQ33678064-D80FE218-4667-428B-BD72-B0669B3B2D02Q33684614-5728BCA1-AADE-413D-B738-0AF5A9E07B9EQ33719099-82576443-2F57-4B05-8FC1-E0EABE996BE5Q34134396-F1FF7328-453D-4B1B-A87B-F8D743B2F4CCQ35694314-9B0D4401-C8CF-45C6-BB5C-A3D8C2626FBEQ36105778-659C02D7-A615-4C8D-8335-D0B4285313D5Q36357873-68EB14A3-3C12-4B55-A48E-1F9373DADDB7Q36429931-DF70DB1F-6736-4A94-AE0D-93C7D7D3DD94Q36594041-178C9EB5-0E2C-4A74-A953-A0277D27FE69Q37018563-73C0435E-1AAB-4110-A302-E9B502EE53DDQ37175517-3CB5DCCD-F7A5-4044-81C7-41C1019203DFQ37254508-43AA14CB-EFC5-4627-8C0B-1B3E93B09B3BQ37323342-035E87B1-29BE-48D9-83AC-C9CC576992F9Q37559230-55A18241-FDB1-4292-8A38-7B59AE362F66Q37725506-582660AC-689C-4C16-9A4D-0EA01CC7689EQ37780777-148AD2AB-5D4C-4351-B4E9-02A680B62ACBQ37837732-D224719F-8CB7-404C-90A3-352405548B5FQ38175297-C402B1A5-E07A-4871-9E18-A0E8064B0A80Q38281261-34D1294A-8215-4439-8325-217B55B33C0CQ38438861-69D8D7A4-153C-4053-A305-EFEAF3C79F7FQ38475375-5B2B0250-8826-4638-BB6E-50BF40CC29FDQ38860980-0D9B25D4-3C25-41D0-A4F4-913F7F02C377Q39377876-471AC178-962D-4A8B-A962-8CF38ED36CBAQ39547114-92CD0996-90C7-48C0-8EB1-DACA7617E5DAQ39652636-8899FF67-8D0B-4029-BFFD-0E6D3D01B1C6Q39943672-8EEC88A1-CCEB-4802-9729-916297D890FEQ40018301-B13BCC15-AFF0-400E-BDD7-762B09BFFF28Q40950385-CE8F200B-3AA2-44BC-A4D8-4F1711AFC316Q41140773-62C491A9-BCA2-4DE8-885D-F95E94BE3E1BQ41949154-AEC2658D-D470-47EB-B589-04EE87CB6514Q42374239-9C20B43F-57C2-4C09-899D-FA9615C4698AQ44505036-008D3C29-C752-4D29-8904-5A82D41E7ED1Q45410313-E75DBF35-9275-4768-B717-427EEF577E46Q46064575-492C03AD-6A02-488F-9A4C-996DB88B4B30Q46077273-898DF922-7071-4F59-8E41-7E36431BC142
P2860
RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
RAS/ERK modulates TGFbeta-regu ...... ancreatic adenocarcinoma cells
@ast
RAS/ERK modulates TGFbeta-regu ...... ancreatic adenocarcinoma cells
@en
RAS/ERK modulates TGFbeta-regu ...... ancreatic adenocarcinoma cells
@nl
type
label
RAS/ERK modulates TGFbeta-regu ...... ancreatic adenocarcinoma cells
@ast
RAS/ERK modulates TGFbeta-regu ...... ancreatic adenocarcinoma cells
@en
RAS/ERK modulates TGFbeta-regu ...... ancreatic adenocarcinoma cells
@nl
prefLabel
RAS/ERK modulates TGFbeta-regu ...... ancreatic adenocarcinoma cells
@ast
RAS/ERK modulates TGFbeta-regu ...... ancreatic adenocarcinoma cells
@en
RAS/ERK modulates TGFbeta-regu ...... ancreatic adenocarcinoma cells
@nl
P2093
P2860
P356
P1433
P1476
RAS/ERK modulates TGFbeta-regu ...... ancreatic adenocarcinoma cells
@en
P2093
Betty L Cabrera
Jennifer A Cabral
Jimmy Y C Chow
John M Carethers
Khai T Quach
Stayce E Beck
P2860
P304
P356
10.1093/CARCIN/BGM159
P407
P577
2007-07-17T00:00:00Z